Study of Daclatasvir (BMS-790052) Add-on to Standard of Care in Treatment- naïve Patients
Public ClinicalTrials.gov record NCT01125189. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2b Study of Daclatasvir in Combination With Peg-Interferon Alfa-2a and Ribavirin in Treatment Naive Subjects With Chronic Hepatitis C Genotype 1 and 4 Infection
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To establish that at least 1 dose of daclatasvir combined with standard of care (pegylated interferon and ribavirin) is safe and well tolerated and demonstrates extended rapid virologic response rates at least 35% greater than those with placebo.
Study identification
- NCT ID
- NCT01125189
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 558 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 2010 (Type not available)
- Primary completion
- Apr 2012 (Actual)
- Completion
- Aug 2012 (Actual)
- Last update posted
- Oct 23, 2015
2010 – 2012
United States locations
- U.S. sites
- 33
- U.S. states
- 18
- U.S. cities
- 29
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alabama Liver & Digestive Specialists (Alds) | Montgomery | Alabama | 36116 | — |
| Scripps Clinic | La Jolla | California | 92037 | — |
| Cli | Los Angeles | California | 90048 | — |
| Desta Digestive Disease Medical Center | San Diego | California | 92114 | — |
| University Of California, San Francisco/Sf General Hospital | San Francisco | California | 94110 | — |
| California Pacific Medical Center | San Francisco | California | 94115 | — |
| Kaiser Permanente Medical Center | San Francisco | California | 94118 | — |
| Transplant Center And Hepatology Clinic, B-154 | Aurora | Colorado | 80045 | — |
| Yale University School Of Medicine | New Haven | Connecticut | 06520 | — |
| University Of Florida Hepatology | Gainesville | Florida | 32610 | — |
| University Of Miami | Miami | Florida | 33136 | — |
| Miami Research Associates | South Miami | Florida | 33143 | — |
| Indiana University | Indianapolis | Indiana | 46202 | — |
| Ochsner Clinic Foundation | New Orleans | Louisiana | 70121 | — |
| Mercy Medical Center | Baltimore | Maryland | 21202 | — |
| Digestive Disease Associates, P.A. | Baltimore | Maryland | 21229 | — |
| Johns Hopkins University | Lutherville | Maryland | 21093 | — |
| Claudia T. Martorell, Md, Llc | Springfield | Massachusetts | 01105 | — |
| James Sungsik Park, M.D. C.N.S.C. | Great Neck | New York | 11201 | — |
| Upper Delaware Valley Infectious Diseases, Pc | Monticello | New York | 12701 | — |
| James J Peters Vamc | The Bronx | New York | 10468 | — |
| University Of North Carolina At Chapel Hill School Of Med | Chapel Hill | North Carolina | 27599 | — |
| Carolinas Center For Liver Disease | Statesville | North Carolina | 28677 | — |
| Options Health Research, Llc | Tulsa | Oklahoma | 74104 | — |
| Healthcare Research Consultants | Tulsa | Oklahoma | 74135 | — |
| University Of Pennsylvania | Philadelphia | Pennsylvania | 19104 | — |
| University Gastroenterology | Providence | Rhode Island | 02905 | — |
| Nashville Medical Research Institute | Nashville | Tennessee | 37205 | — |
| North Texas Research Institute | Arlington | Texas | 76012 | — |
| St. Luke'S Episcopal Hospital - Baylor College Of Medicine | Houston | Texas | 77030 | — |
| Alamo Medical Research | San Antonio | Texas | 78215 | — |
| Metropolitan Research | Fairfax | Virginia | 22031 | — |
| Dean Clinic | Madison | Wisconsin | 53715 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 31 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01125189, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 23, 2015 · Synced Nov 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01125189 live on ClinicalTrials.gov.